Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Diabetes & Endocrinology

Topics

Engineering

Internal Medicine

Medicine

Endocrinology

Endocrinology, Diabetes And Metabolism

Show all topics

DOI

10.1016/s2213-8587(17)30317-0